What is the long-term trend for Aquestive Therapeutics, Inc.'s capitalized contract cost, net?

Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s capitalized contract cost, net has grown at a -20.8% compound annual growth rate (CAGR), from $715K to $449K.

Aquestive Therapeutics, Inc. AQST Capitalized Contract Cost, Net

Capitalized Contract Cost, Net at other companies

Arthur J. GallagherAJG

$220M—

FortinetFTNT

$753.7M+18.5%

Innoviva, Inc.INVA

$52.68M-20.8%

Xerox Holdings CorporationXRX

$160M+14.3%

BGC Group, Inc.BGC

$0—

Expeditors International of WashingtonEXPD

$179.53M-35.8%

Other financials

Income statement

See full

Revenue$14.4M+65.7%

Gross profit$11.0M+117%

Operating income-$4.2M+78.3%

Net income-$8.1M+64.9%

EPS (diluted)-$0.07+70.8%

Balance sheet

See full

Cash & equivalents$110.7M+61.3%

Total debt$64.4M+7.4%

Total equity-$34.1M+44.1%

Total assets$141.1M+38.0%

Cash flow

See full

Operating cash flow-$14.8M+36.7%

CapEx$52.0K-61.5%

Free cash flow-$14.9M+36.9%

Valuation

See full

Market cap$560.13M+73.5%

Enterprise value$513.76M+63.6%

P/S11.1×+5.2×

Profitability

See full

Gross margin63.5%-4.9pp

Operating margin-111.2%+96.3pp

Net margin-137.1%+80.7pp

FCF margin-88.2%-2.2pp

Returns & leverage

See full

Return on equity145.1%—

Debt / equity-1.9×—

Current ratio4.1×-0.8×

Where this comes from

Reported directly by Aquestive Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CapitalizedContractCostNet.

The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aquestive Therapeutics, Inc.'s capitalized contract cost, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aquestive Therapeutics, Inc.'s capitalized contract cost, net?: Aquestive Therapeutics, Inc. (AQST) reported capitalized contract cost, net of $442K in Q1 2026.
How has Aquestive Therapeutics, Inc.'s capitalized contract cost, net changed year-over-year?: Aquestive Therapeutics, Inc.'s capitalized contract cost, net decreased by 6.4% year-over-year, from $472K to $442K.
What is the long-term trend for Aquestive Therapeutics, Inc.'s capitalized contract cost, net?: Over 2 years (2023 to 2025), Aquestive Therapeutics, Inc.'s capitalized contract cost, net has grown at a -20.8% compound annual growth rate (CAGR), from $715K to $449K.